Our people–a story of
competence and collaboration


Cultivating a diverse set of expertise and knowledge.

We employ an exemplary set of professionals with diverse skill sets, all working toward a common goal—invested in the health and care of the patient, knowing financial returns follow well-being. Our people have come together from all over the world and represent a culture of competence and collaboration that is shaping Nan Fung Life Sciences for generations to come.


We’re solving critical challenges. Be part of the answer.
Meet our exemplary team


Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss

INDIANAPOLIS and BOSTON, Oct. 18, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today…

Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology

Oculis is focused on becoming a leading global ophthalmic biopharmaceutical company with product candidates to address areas of significant medical…

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

Study met both co-primary endpoints and all secondary endpoints. At week eight, 67.3% of individuals treated with roflumilast foam achieved…

Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced positive preliminary results from its ongoing Phase 1b proof-of-concept study of…